Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Abstract Ahead of Print

Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems

Volume:19
Vipin Mohan Dan, Thania Sara Varghese, Gayathri Viswanathan and Sabulal Baby*

ERGIC3 silencing additively enhances the growth inhibition of BFA on lung adenocarcinoma cells

Volume:19
Qiurong Zhao, Mingsong Wu, Xiang Zheng, Lei Yang, Zhimin Zhang, Xueying Li* and Jindong Chen*

C/EBPα regulates FOXC1 to modulate tumor growth by interacting with PPARγ in Hepatocellular carcinoma

Volume:19
Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun*, Li-Li Zhao*, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang and Guang-Jun Ma